These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6808087)

  • 1. The paradoxical effect of central nervous system stimulants on hyperactivity: a paradox unexplained by the rate-dependent effect.
    Millard WJ; Standish LJ
    J Nerv Ment Dis; 1982 Aug; 170(8):499-501. PubMed ID: 6808087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 3. Attention deficit disorder: evaluation and treatment.
    Dulcan MK
    Pediatr Ann; 1985 May; 14(5):383-5, 388-90, 393-400. PubMed ID: 2860631
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Brasić (2007): psychomotor study of children with ADHD.
    Pedersen SJ
    Percept Mot Skills; 2008 Jun; 106(3):891-2. PubMed ID: 18712212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of Anxiety Symptoms in Response to Stimulants in a Patient With Attention-Deficit/Hyperactivity Disorder and Generalized Anxiety Disorder.
    Suhaiban H; Javanbakht A
    Prim Care Companion CNS Disord; 2018 May; 20(3):. PubMed ID: 29917333
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
    Bizot JC; David S; Trovero F
    Neurosci Lett; 2011 Feb; 489(1):20-4. PubMed ID: 21129437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys.
    Rapoport JL; Buchsbaum MS; Zahn TP; Weingartner H; Ludlow C; Mikkelsen EJ
    Science; 1978 Feb; 199(4328):560-3. PubMed ID: 341313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
    Kollins SH; Shapiro SK; Newland MC; Abramowitz A
    Exp Clin Psychopharmacol; 1998 Nov; 6(4):375-389. PubMed ID: 9861552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis.
    Kavale K
    J Learn Disabil; 1982 May; 15(5):280-9. PubMed ID: 6123539
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
    Rowley HL; Kulkarni RS; Gosden J; Brammer RJ; Hackett D; Heal DJ
    J Psychopharmacol; 2014 Mar; 28(3):254-69. PubMed ID: 24327450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methylphenidate on motor performance and attention in children with developmental coordination disorder and attention deficit hyperactive disorder.
    Bart O; Daniel L; Dan O; Bar-Haim Y
    Res Dev Disabil; 2013 Jun; 34(6):1922-7. PubMed ID: 23584172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol-induced hyperactivity in neonatal rats: effect of lithium and stimulants.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Jan; 16(1):1-5. PubMed ID: 6799967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
    Lurie S; O'Quinn A
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effects of amphetamine on preweanling and postweanling rats.
    Campbell BA; Randall PJ
    Science; 1977 Mar; 195(4281):888-91. PubMed ID: 557236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of stimulant drugs on curiosity behaviors of hyperactive boys.
    Fiedler NL; Ullman DG
    J Abnorm Child Psychol; 1983 Jun; 11(2):193-206. PubMed ID: 6619433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
    Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
    J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.